Home » Cancer Vaccine Passes Early Test in Melanoma
Cancer Vaccine Passes Early Test in Melanoma
Researchers have found a way to use a person’s own cells to produce a vaccine that has kept multiple melanoma patients in complete remission for up to four years.
Medpage Today
Medpage Today
Upcoming Events
-
07May
-
14May
-
30May